The number of young women presenting with STEMI is increasing worldwide, and they face a particularly worrisome risk of mortality due to under-diagnosis and treatment delay, according to a EuroPCR conference session led by Drs. Alaide Chieffo and Josepa Mauri. The causes of STEMI in women may differ from those in men, calling for a range of diagnostic tools. "We want to take the time to remind interventionalists that this is an urgent issue," Mauri said. "This is a question of saving lives."
Published in Brief: